Abstract:The proportion of the elderly population continues to increase due to the global increase in longevity. Heart failure with preserved ejection fraction (HFpEF) is common in the elderly due to cellular aging, myocardial stiffness, and multiple comorbidities. This age group is often under-represented in clinical trials. In this narrative review, we looked into the latest evidence-based lines of management of HFpEF in this vulnerable cohort. In this narrative review, we brought the latest evidence on the treatment of HFpEf in the elderly. We searched the largest three scientific databases (Pubmed, Google Scholar, and EMBASE) using the search words (elderly, HFpEF, heart failure with preserved ejection fraction, guidelines, treatment, and management) in different combinations. To date, screening for and treatment of the causes of HFpEF (such as hypertension, coronary artery disease [CAD], valvular heart disease, and cardiac amyloidosis) and associated comorbidities (such as diabetes mellitus [DM], iron deficiency, obesity, and thyroid dysfunction) are the main line of management of HFpEF. A multidisciplinary team, including an HF specialist cardiologist, an HF nurse, a geriatrician, a dietician, a psychologist, a physiotherapist, and an occupational therapist, should manage HFpEF elderly patients. Other specialist input may be needed according to the patient's requirements. The evidence on the effective management of HFpEF in the elderly age group is scarce and controversial. Some studied non-pharmacological approaches include supervised exercise training, pulmonary artery pressure monitoring, and the interatrial shunt device (an emerging modality that includes a small percutaneously inserted interatrial left to right valve aiming to reduce the left atrial and pulmonary wedge pressures). These modalities can only improve the symptoms and HF hospitalizations without robustly impacting cardiovascular (CV) death. Among the pharmacological approaches to treat HFpEF, only the sodium-glucose cotransporter 2 (SGLT-2) inhibitors proved efficacy in reducing the hard outcomes of CV death, HF hospitalizations, and urgent visits for HF when used in elderly HFpEF patients, irrespective of the presence of diabetes mellitus. Diuretics are only beneficial to alleviate the symptoms of fluid overload, with a risk of renal impairment in volume-depleted patients. The evidence on the effectiveness of other HF-specific disease-modifying agents in elderly HFpEF patients is controversial. Elderly patients have a higher risk of having side effects from HF medications due to the higher prevalence of polypharmacy, cognitive decline, and impairment of kidney and liver functions. Therefore, cautious initiation of HF treatment with a close follow-up of the blood pressure, liver functions, kidney functions, and electrolytes are of utmost importance.

Considerations Regarding Management of Heart Failure in Older Adults

Heart Failure in Older People Part 1: Disease State Review and Lifestyle Interventions

Age-Specific Differences In Non-Cardiac Comorbidities Among Elderly Patients Hospitalized With Heart Failure: A Special Focus On Young-Old, Old-Old, And Oldest-Old

Aging of the United States Population: Impact on Heart Failure

Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment

Heart Failure with Preserved Ejection Fraction Based on Aging and Comorbidities

Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers

Management of Heart Failure With Preserved Ejection Fraction in Elderly Patients: Effectiveness and Safety

[Guidelines, heart failure and the elderly]

Congenital heart diseases in aged patients: clinical features, diagnosis, and therapeutic indications based on the analysis of a twenty five-year Medline search.

Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association

Cardiogeriatrics: the current state of the art

Polypharmacy in Older Heart Failure Patients: a Multidisciplinary Approach

Medication Complexity Among Older Adults with HF: How Can We Assess Better?

Management of Acute Coronary Syndromes in Older People: Comprehensive Review and Multidisciplinary Practice-Based Recommendations

High Prevalence of Geriatric Conditions Among Older Adults With Cardiovascular Disease

Pharmacological and Non-Pharmacological Advancements in Heart Failure Treatment

The effect of management of older patients with heart failure by general physicians on mortality and hospitalization rates: a retrospective cohort study

Perspectives on Implementing a Multidomain Approach to Caring for Older Adults With Heart Failure

Non-cardiac comorbidities in heart failure: an update on diagnostic and management strategies

Frailty, Sarcopenia, Cachexia, and Malnutrition in Heart Failure